Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "financing"

137 News Found

Lyndra Therapeutics raises US$101 million in Series E funding
News | December 25, 2023

Lyndra Therapeutics raises US$101 million in Series E funding

Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners


Aster to separate its India and GCC businesses to unlock value
News | November 29, 2023

Aster to separate its India and GCC businesses to unlock value

Both the India and GCC entities will be operated by separate dedicated management teams


G20 New Delhi Leaders' Declaration on strengthening global health
Policy | September 11, 2023

G20 New Delhi Leaders' Declaration on strengthening global health

The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach


G20 Health Minister’s Meeting concludes in Gandhinagar, Gujarat
Policy | August 21, 2023

G20 Health Minister’s Meeting concludes in Gandhinagar, Gujarat

Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting


Galmed Pharmaceuticals forms partnership with OnKai
News | May 08, 2023

Galmed Pharmaceuticals forms partnership with OnKai

Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications


Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer
People | May 04, 2023

Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer

He has over two decades of leadership experience as an innovative strategic planner in finance diligence


Fibe partners with Pristyn Care to power affordable quality healthcare across India
Healthcare | April 15, 2023

Fibe partners with Pristyn Care to power affordable quality healthcare across India

Affordability is key to providing accessible healthcare for Bharat.


HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
Biotech | April 01, 2023

HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData

SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development


Pfizer acquires Seagen for US$ 43 billion to battle cancer
News | March 14, 2023

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology


Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
Policy | February 02, 2023

Budget 2023-24: Industry welcomes focus on medical research and pharma innovation

It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047